Close Menu
Home » GE Healthcare

GE Healthcare

Dec 31, 2015

NeoGenomics Completes Clarient Acquisition

The cancer genetics testing provider acquired its new business unit from GE Healthcare.

Oct 28, 2015

With Clarient Purchase, NeoGenomics Hoping to Offer Most Comprehensive Cancer Genetics Test Menu

Premium

By buying Clarient, NeoGenomics hopes to move closer to its goal of becoming America's top cancer genetic testing lab.

Oct 21, 2015

NeoGenomics to Acquire Clarient From GE

NeoGenomics and GE Healthcare will also collaborate on a bioinformatics initiative for personalized oncology.

Jul 14, 2015

Axiogenesis Inks Sublicensing Agreement with GE Healthcare for Stem Cell IP

The deal gives Axiogenesis access to IP that will allow it to commercialize stem cell-derived assays and disease models for use in drug discovery.

Dec 04, 2014

Broad Licenses CRISPR/Cas9 IP to GE Healthcare, Sigma-Aldrich

The licenses provide non-exclusive access to the IP for research applications.

Nov 04, 2014

IP Roundup: GE, Luminex, and University of Tokyo Win US Patents

Premium

General Electric has been awarded

Oct 08, 2014

GE/Clarient Setting Up Lab Network, Database to Advance Personalized Rx for GSK, Other Pharmas

Premium

Originally published Oct. 3.

Sep 30, 2014

GE Healthcare's Clarient, GSK Creating Clinical Lab Network to Improve Cancer Dx

NEW YORK (GenomeWeb) – GE Healthcare today announced a deal between its affiliate Clarient Diagnostic Services and GlaxoSmithKline to create a network of clinical laboratories to identify genetic mutations associated with different tumor types.

Sep 25, 2014

IP Update: Recent Patents Awarded to Alnylam, GE Healthcare, Sanofi, and More

Premium

Title: Treatment of Cancer by Inhibition of IGFBPs and Clusterin
Patent Number: 8,835,401
Filed: May 29, 2013

Sep 04, 2014

Product Watch: GE Healthcare Illustra Single-Cell DNA Amplification Kit

Premium

GE Healthcare this week launched the illustra Single Cell GenomiPhi DNA amplification kit from.

Pages

The Scan

To Explain What They Mean

The US National Institutes of Health's All of Us project awarded $4.6 million to the company Color to develop a genetic counseling resource for the program.

A Few Days

The Times of India reports on a pilot study that used genomic testing to determine whether patients had drug-resistant tuberculosis.

Slightly Larger Pool

New guidelines say that more women may benefit from genetic testing for hereditary breast or ovarian cancer, according to the Los Angeles Times.

Cell Studies Explore Microbiome Genes, Tumor Influence, More

In Cell this week: small proteins identified among human microbiome, role for tumor microbes in pancreatic cancer survival, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.